The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
A Meta-Analysis of D-Cycloserine and the Facilitation of Fear Extinction and Exposure Therapy
Abstract
Background Translational research suggests that D-cycloserine (DCS), a partial N-methyl-D-aspartate (NMDA) receptor agonist, might facilitate fear extinction and exposure therapy by either enhancing NMDA receptor function during extinction or by reducing NMDA receptor function during fear memory consolidation. This article provides a quantitative review of DCS-augmented fear extinction and exposure therapy literature.Methods English-language journal articles that examined DCS augmented with fear extinction or exposure therapy were identified through public databases from June 1998 through September 2007, through references of originally identified articles and contact with DCS investigators. Data were extracted for study author, title, and year; trial design; type of subject (animal vs. human; clinical vs. nonclinical); sample size, DCS dose, and timing in relation to extinction/exposure procedures; dependent variable; group means and SDs at post-extinction/exposure; and follow-up outcome.Results D-cycloserine enhances fear extinction/exposure therapy in both animals and anxiety-disordered humans. Gains generally were maintained at follow-up, although some lessening of efficacy was noted. D-cycloserine was more effective when administered a limited number of times and when given immediately before or after extinction training/exposure therapy.Conclusions This meta-analysis suggests that DCS is a useful target for translational research on augmenting exposure-based treatment via compounds that impact neuroplasticity. D-cycloserine 's major contribution to exposure-based therapy might be to increase its speed or efficiency, because the effects of DCS seem to decrease over repeated sessions. This information might guide translational researchers in discovering more selective and/or effective agents that effectively enhance (or reduce) NMDA receptor function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“we know that the human amygdala plays a role in extinction learning.”
From Prefrontal cortex, amygdala, and threat processing: implications for PTSD (2022) · cites this paper as [104]
In the citing paper
“From rodent research showing that intra-amygdala infusion of the NMDA receptor agonist d-cycloserine, which enhances NMDA-dependent plasticity, facilitates extinction learning, and successful translation of this work to humans (see [104] for review), we know that the human amygdala plays a role in extinction learning.”
From Prefrontal cortex, amygdala, and threat processing: implications for PTSD (2022) · cites this paper as [104]
In the citing paper
“Pre-session dosing has been the strategy employed in all studies to date (1).”
From D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia (2013) · cites this paper as [1]
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,603
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
Meta-Analytic Procedures for Social Research
Rosenthal, R. (1991) · doi:10.4135/9781412984997 · Cited by 4,635
Meta-Analytic Procedures for Social Research.
Metcalfe, A., & Rosenthal, R. (1994) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2348600 · Cited by 4,249
Meta-analysis in social research
(1982) · Evaluation and Program Planning · doi:10.1016/0149-7189(82)90011-8 · Cited by 3,896
Mattick, R. P., & Clarke, J. C. (1998) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(97)10031-6 · Cited by 3,367
The practice of behavior therapy
Wolpe, J. (1969) · Cited by 2,343
The Yale-Brown Obsessive-Compulsive Scale: measures of internal consistency.
Kim, S.-W., Dysken, M., Pheley, A., & Hoover, K. M. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90039-6 · Cited by 2,333
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Research works printed but not linked: 1
- Ledgerwood, 2004, D-cycloserine and the facilitation of extinction of conditioned fear: Consequences for reinstatement, Behav Neurosci, 118, 505, 10.1037/0735-7044.118.3.505 · DOI
Cited by
Sorted by citations
Items 401–500 of 509
Fear-related anxiety disorders and posttraumatic stress disorder
Moreland-Capuia, A. R., Vahabzadeh, A., Gillespie, C. F., & Ressler, K. J. (2023) · Neurobiology of Brain Disorders · doi:10.1016/b978-0-323-85654-6.00005-8 · Cited by 3
Saporta, L., Feldman, R., Levi, L. W., Davidson, M., Burshtein, S., Gur, R. C., Zagoory‐Sharon, O., Amiaz, R., Park, J., Davis, J. M., et al. (2024) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgae022 · Cited by 2
Murgueitio, N., Propper, C. B., Sullivan, R. M., & Sheridan, M. A. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106752 · Cited by 2
Advances in Pharmacotherapy for Pediatric Anxiety Disorders
Rynn, M. A., Puliafico, A. C., Heleniak, C. M., Rikhi, P., Ghalib, K., & Vidair, H. B. (2011) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.9.3.foc299 · Cited by 2
Thomaidou, M. A., Blythe, J. S., Veldhuijzen, D. S., Peerdeman, K. J., van Lennep, J. P. A., Giltay, E. J., Cremers, H. R., & Evers, A. W. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-23769-7 · Cited by 2
Augmentation of Psychotherapy with D-Cycloserine in Patients with Anxiety Disorders
Lautenbacher, L. M., Pyrkosch, L., Mascarell-Maricic, L., & Ströhle, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_446 · Cited by 2
Treatment of Sexual Obsessive-Compulsive Symptoms During Exposure and Response Prevention
Reid, A. M., Flores, C., Olsen, B. T., Barthle-Herrera, M. A., Rahmani, M., Rakhshani, A. C., Nguyen, M. L., Geffken, G. R., & McNamara, J. P. H. (2015) · Springer eBooks · doi:10.1007/978-3-319-17139-5_3 · Cited by 2
Progrès récents dans le traitement des troubles anxieux.
Antony, M. M. (2011) · Canadian Psychology/Psychologie canadienne · doi:10.1037/a0022376 · Cited by 2
Fernández‐Arias, I., Labrador, F. J., Estupiñá, F. J., Bernaldo‐de‐Quirós, M., González, P. A., Blanco, C., & Gómez, L. (2013) · Psicothema · doi:10.7334/psicothema2012.238 · Cited by 2
Konfrontationstherapie im Fokus
Mühlberger, M., & Voderholzer, U. (2015) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-015-1383-z · Cited by 2
Reaktionen auf schwere Belastungen und Anpassungsstörungen
Paulzen, M., & Gründer, G. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_80 · Cited by 2
Pharmacological assistance for psychotherapy
Lochtenberg, J., Kirshenbaum, A. P., & Johnson, M. W. (2021) · Emerging Trends in Drugs Addictions and Health · doi:10.1016/j.etdah.2021.100017 · Cited by 2
An Evaluation of the Effects of D-Cycloserine on Operant Learning and Response Recovery
Martín, C. S., Alfaro, F., Bustamante, J., Laborda, M. A., Mallea, J., & Míguez, G. (2022) · Psykhe (Santiago) · doi:10.7764/psykhe.2021.33531 · Cited by 2
Histone Deacetylase Inhibitors: A Novel Therapeutic Approach for Cognitive Disorders
Labrie, V. (2011) · Springer eBooks · doi:10.1007/978-3-642-17426-1_12 · Cited by 2
The Neural Substrates of Fear Extinction
Lueken, U., & Maslowski, N. I. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3342-2_5 · Cited by 3
Update on the Treatment of Pediatric Obsessive-Compulsive Disorder
Schneider, S. C., & Storch, E. A. (2017) · Psychiatric Annals · doi:10.3928/00485713-20171011-01 · Cited by 2
The role of frontal-subcortical circuits in the development of obsessive-compulsive disorders
Kutlubaev, M. A. (2016) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2016-2-107-112 · Cited by 2
Approaches to Treatment Resistance
Pallanti, S., Grassi, G., & Cantisani, A. (2012) · Wiley eBooks · doi:10.1002/9781119941125.ch5 · Cited by 2
From non-pharmacological interventions to therapeutic targets for the treatment of PTSD
Hendriksen, H. M. A. (2012) · Utrecht University Repository (Utrecht University) · Cited by 2
Introduction to the Special Issue: Recent Developments in Childhood Obsessive Compulsive Disorder
Storch, E. A., & McKay, D. (2010) · Child & Youth Care Forum · doi:10.1007/s10566-010-9099-1 · Cited by 2
Pharmacologic Augmentation of Extinction Learning During Exposure Therapy for PTSD
Neylan, T. C. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14030386 · Cited by 2
Augmentation of psychotherapy with d-cycloserine for anxiety disorders
Ipser, J., Sander, C., Seifan, A., & Stein, D. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007803 · Cited by 2
Fear Not: Neurobiological Mechanisms of Fear and Anxiety
Klumpers, F. (2007) · Utrecht University Repository (Utrecht University) · Cited by 2
Pilot controlled trial of d-serine for the treatment of post-traumatic stress disorder
Heresco‐Levy, U., Vass, Á., Bloch, B., Wolosker, H., Dumin, E., & Balan, L. (2009) · PsycEXTRA Dataset · doi:10.1037/e717702011-017 · Cited by 2
Vorstenbosch, V., Newman, L., & Antony, M. M. (2013) · Wiley eBooks · doi:10.1002/9781118528563.wbcbt03 · Cited by 3
Durrant, A. R., & Heresco‐Levy, U. (2013) · Springer eBooks · doi:10.1007/978-3-642-27772-6_7018-1 · Cited by 2
Nowakowski, M. E., Rogojanski, J., & Antony, M. M. (2013) · Wiley eBooks · doi:10.1002/9781118528563.wbcbt41 · Cited by 2
Solem, S. (2010) · NORA - Norwegian Open Research Archives · Cited by 2
Manfro, G. G., Heldt, E., Cordioli, A. V., & Otto, M. W. (2008) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.1590/s1516-44462008000600005 · Cited by 1
Pachana, N. A., & Byrne, G. J. (2021) · Cambridge University Press eBooks · doi:10.1017/9781139087469.014 · Cited by 1
A systematic review of pharmacological effects on human aversive memory
Xia, Y., Quednow, B. B., & Bach, D. R. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106548 · Cited by 1
Effect of app-based mindfulness on extinction recall – a 7T-fMRI study
Björkstrand, J., Olsson, E., Clancy, O., Möller, S., Björkman-Burtscher, I. M., Raheja, N., Sjöström, D., Persiani, M. T. L., Staiano, W., & Kirk, U. (2026) · Scientific Reports · doi:10.1038/s41598-026-45569-z · Cited by 1
D-Cycloserine Augmentation of Cognitive-Behavioral Therapy for the Treatment of Anxiety Disorders
Janicak, P. G., Dattilo, N. C., Manos, R. C., Storch, E. A., & Goddard, A. W. (2011) · Psychopharm Review · doi:10.1097/01.psyphr.0000399653.06660.fa · Cited by 1
Posttraumatic Stress Disorder in Children and Adolescents
Grasso, D. J., & Kaufman, J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6599-7_10 · Cited by 1
D-cycloserine en exposure in de behandeling van posttraumatische stressstoornis1
de Kleine, R. A., & van Minnen, A. (2012) · GZ - Psychologie · doi:10.1007/s41480-012-0059-2 · Cited by 1
Potentiation of the Startle Reflex as a Behavioral Measure of Anxiety
Gewirtz, J. C., & Radke, A. K. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3777-6_11 · Cited by 1
Factors Associated With Parental Consent to use D-Cycloserine for Child Anxiety
Byrne, S., Rapee, R. M., & Sweller, N. (2017) · Behaviour Change · doi:10.1017/bec.2017.5 · Cited by 1
Promising Psychological Treatments
Kearns, M. C., & ROTHBAUM, B. O. (2012) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780195399066.013.0032 · Cited by 1
MicroRNAs in posttraumatic stress disorder
Snijders, C., Escoto, A. I. H., Baker, D. G., Hauger, R. L., van den Hove, D., Kenis, G., Nievergelt, C. M., Boks, M. P., Vermetten, E. H. G. J. M., Gage, F. H., et al. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823039-8.00001-0 · Cited by 1
Current and Experimental Treatments for Anxiety Disorders
Guastella, A. J., Norton, A., Alvares, G. A., & Song, Y. J. C. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0040 · Cited by 1
Yılmaz, F. B., Satıcı, S. A., Okur, S., Kütük, H., & Karaağaç, Z. G. (2024) · Current Issues in Personality Psychology · doi:10.5114/cipp/190902 · Cited by 2
Vermeende contra-indicaties voor (imaginaire) exposurebehandeling van PTSS onder de loep
van Minnen, A., Harned, Zøllner, L., & Mills, K. L. (2013) · Radboud Repository (Radboud University) · Cited by 1
Kapfhammer, H. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_58 · Cited by 1
Anxiety Disorders: Social Anxiety Disorder and Specific Phobia
McCabe, R. E., Hood, H. K., & Antony, M. M. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch54 · Cited by 1
Obsessive‐Compulsive Disorder: Assessment and Treatment
Amitai Abramovitch, A., Elliott, C. M., Wilhelm, S., Steketee, G. S., & Wilson, A. C. (2014) · Wiley eBooks · doi:10.1002/9781118775349.ch51 · Cited by 1
Klassische Konditionierung als Erklärungsprinzip für klinisch bedeutsame Ängste
Michael, T., & Ehlers, A. (2008) · Zeitschrift für Klinische Psychologie und Psychotherapie · doi:10.1026/1616-3443.37.4.221 · Cited by 1
Novel approaches for treating schizophrenia
Davis, M. C., & Marder, S. R. (2012) · doi:10.2217/ebo.12.31 · Cited by 1
Chao, M., Wong, A. V., & McConnell, B. L. (2021) · Research Square · doi:10.21203/rs.3.rs-144660/v1 · Cited by 1
Maeng, L. Y., Rosenfeld, D., Simandl, G. J., Koehler, F., Senko, A. W., Moon, J., Varnavides, G., Murillo, M. F., Reimer, A. E., Wald, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.24.449506 · Cited by 1
Exposure Therapies and Stress Inoculation: A Brief Overview
Phillips, D., & Lauterbach, D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-097086-8.21050-7 · Cited by 2
Panic Disorder and Agoraphobia
Brown, L. A., & Craske, M. G. (2017) · Wiley eBooks · doi:10.1002/9781118877142.ch4 · Cited by 1
Finnegan, S., Harrison, O. K., Booth, S., Dennis, A., Ezra, M., Harmer, C. J., Herigstad, M., Guillaume, B., Nichols, T. E., Rahman, N. M., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4007187 · Cited by 1
Guastella, A. J., & Alvares, G. A. (2012) · Wiley eBooks · doi:10.1002/9781119945901.ch5 · Cited by 1
Candido, D. (2011) · Springer eBooks · doi:10.1007/978-0-387-79061-9_162 · Cited by 1
(2008) · Biological Psychiatry · doi:10.1016/s0006-3223(08)00575-1 · Cited by 1
Price, M. (2022) · Digital Archive @ GSU · doi:10.57709/1350605
What Can Fear Conditioning Tell Us About Posttraumatic Stress Disorder?
Dębiec, J., & LeDoux, J. E. (2011) · Wiley eBooks · doi:10.1002/9781118083222.ch20
Glutamate Transmission Enhancement for Treatment of PTSD
Risbrough, V. B. (2009) · doi:10.21236/ada506358
de Leeuw, A. S. (2013) · Utrecht University Repository (Utrecht University)
Thérapies comportementales et cognitives
Pélissolo, A., & Montefiore, D. (2009) · Elsevier eBooks · doi:10.1016/b978-2-294-70563-2.00003-x
Psychiatric symptoms and disorders in old age: prevalence, course and diagnostic thresholds
Sigström, R. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Myers, K. M., & Carlezon, W. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.004
An Evolutionarily Conserved Depression Mechanism: Are There Implications for Psychotherapy?
Koenigsberg, H. W. (2009) · Neuropsychoanalysis · doi:10.1080/15294145.2009.10773599
Dubrovina, N. I., & Dv, Z. (2013) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-013-9748-6
Lonsdorf, T. B. (2010) · Figshare
Understanding the causes of anxiety
Simpson, H. B., Neria, Y., Lewis‐Fernández, R., & Schneier, F. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777578.015
Biological Systems that Control Conditioned Fear Memory
Sekiguchi, M. (2014) · Anxiety Disorder Research · doi:10.14389/adr.5.85
Treatment of posttraumatic stress disorder
Sullivan, G. M., Suh, E. J., & Neria, Y. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777578.026
Translational approaches to the treatment of anxiety disorders
Gillespie, C. F., Weiss, T., & Ressler, K. J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.003
Manfro, G. G., Heldt, E., Cordioli, A. V., & Otto, M. W. (2008)
Treatment Choice Among Combat Veterans
Dietrich, Z. C. (2017)
DeLeon, P., & Sammons, M. T. (2009)
Kerst, W. F. (2013) · Defense Technical Information Center (DTIC) · doi:10.21236/ad1012995
Current and potential pharmaceutical possibilities in PTSD treatment
Havlikova, P. (2017) · Psychiatrie pro praxi · doi:10.36290/psy.2017.010
Muse, M. D., & Stahl, S. M. (2017) · Wiley eBooks · doi:10.1002/9781119152606.ch6 · Cited by 1
D-Cycloserine: A Novel Antidepressant to Be Explored?
Brainch, N., Virani, S., & Bazzi, L. (2018) · Psychiatric Annals · doi:10.3928/00485713-20180308-01
Fernández‐Arias, I., de Madrid, U. C., Bernaldo‐de‐Quirós, M., de Madrid, U. C., Labrador, F. J., de Madrid, U. C., Estupiñá, F. J., de Madrid, U. C., Labrador, M., & de Madrid, U. C. (2018) · Papeles del Psicólogo - Psychologist Papers · doi:10.23923/pap.psicol2019.2876
Pharmacologic-Augmented Treatments
Schneider, S. C., & Storch, E. A. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108235655.020
Die Theorie der Behandlung in der Integrativen Therapie
Leitner, A. (2020) · Springer eBooks · doi:10.1007/978-3-662-60594-3_6
Treating Posttraumatic Stress Disorder: A Timely Update on Therapeutic Strategies
Tucker, L. D., Li, Y., & Zhang, Q. (2020) · Journal of Psychology and Psychotherapy Research · doi:10.12974/2313-1047.2020.07.10
Augmentation of Psychotherapy with D-Cycloserine in Patients with Anxiety Disorders
Lautenbacher, L. M., Pyrkosch, L., Mascarell-Maricic, L., & Ströhle, A. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_446-1
The Role(s) of Psychopharmacology in the Treatment of PTSD
Baig, M. R., & Roache, J. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00150-x · Cited by 1
Mirabel-Sarron, C., Sarron, P.-Y., & Vera, L. (2018) · Dunod eBooks · doi:10.3917/dunod.mirab.2018.02.0263
Current awareness in human psychopharmacology
(2008) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.971
Ryan, F. (2013) · Wiley eBooks · doi:10.1002/9781118316474.refs
Durrant, A. R., & Heresco‐Levy, U. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_7018
Morgan, C. J. A., & Curran, V. H. (2010) · Springer eBooks · doi:10.1007/978-3-540-68706-1_177
Morgan, C. J. A. (2014) · Springer eBooks · doi:10.1007/978-3-642-27772-6_177-2
Reid, J. M., & McKay, D. (2013) · Oxford University Press eBooks · doi:10.1093/obo/9780199828340-0006
(2014) · Elsevier eBooks · doi:10.1016/b978-0-12-420071-5.16001-6
Novel Approaches for Treating Anxiety Disorders
Sturman, D. A., Kaufman, M. L., Bigony, C. E., & Ressler, K. J. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0039
(2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615372997.as06
Morgan, C. J. A., & Curran, H. V. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_177
(2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615372300.as06
Durrant, A. R., & Heresco‐Levy, U. (2014) · Springer eBooks · doi:10.1007/978-3-642-27772-6_7018-2
Treatment of Psychiatric Comorbidities in Tourette Syndrome
Cardona, F., & Rizzo, R. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780197543214.003.0027
Arch, J. J., Kirk, A., & Craske, M. G. (2017) · Psychopathology · doi:10.1002/9781394258949.ch3
Woodruff‐Borden, J., Lee, A. M., & Gramszlo, C. (2018) · Wiley eBooks · doi:10.1002/9781394258970.ch9
Metadata
- Authors
- Norberg, M. M., Krystal, J. H., & Tolin, D. F.
- Affiliations
- Yale University (US)
- Corresponding author
- Tolin, David F.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 63
- Issue
- 12
- Pages
- 1118-1126
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2159630298
- Cited by
- 510
- References
- 121
- Citations by year
- 2026: 10 · 2025: 9 · 2024: 8 · 2023: 8 · 2022: 15 · 2021: 13 · 2020: 12 · 2019: 16 · 2018: 28 · 2017: 28 · 2016: 23 · 2015: 50 · 2014: 37 · 2013: 53 · 2012: 51
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- D-cycloserine, fear extinction, exposure therapy, NMDA receptor agonist, anxiety disorders, fear memory consolidation, neuroplasticity, augmentation therapy, translational research
- MeSH terms
- Animals, Anxiety Disorders, Combined Modality Therapy, Cycloserine, Desensitization, Psychologic, Extinction, Psychological, Fear, Humans, Implosive Therapy, Neuronal Plasticity, Receptors, N-Methyl-D-Aspartate, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review